Rock Springs Capital portfolio
50 tracked investments, 3 on the map, $1.3B raised across the mapped portfolio.
Rock Springs Capital50 investments · 3 on the map · $1.3B raised
Imperative Care
DELFI Diagnostics
Genesis Molecular AISeries B
Also in the portfolio
- Honor
- Vigil Neuroscience
- Biomea Fusion
- Latigo Biotherapeutics
- Crinetics Pharmaceuticals
- Acumen Pharmaceuticals
- Gossamer Bio
- Treeline Biosciences
- MOMA Therapeutics
- Everest Medicines
- Innovent Biologics
- CinCor Pharma
- Enliven Therapeutics
- Xilio Therapeutics
- ArsenalBio
- Sagimet Biosciences
- Synthekine
- Zai Lab
- BeiGene
- Spruce Biosciences
- City Therapeutics
- Affinivax
- Ascendis Pharma
- Simcha Therapeutics
- Galera Therapeutics
- Vets First Choice
- Braeburn
- Adaptive Biotechnologies
- dMed
- Theseus Pharmaceuticals
- Cullinan Therapeutics
- Akero Therapeutics
- Clinipace
- Fusion Pharmaceuticals
- Pulmonx
- Dermira
- Ra Pharmaceuticals
- Aeglea BioTherapeutics
- Chinook Therapeutics
- Homology Medicines
- Clearside Biomedical
- Proteostasis Therapeutics
- Imara
- Chiasma
- Atea Pharmaceuticals
- Advanced Accelerator Applications
Investors similar to Rock Springs Capital
T. Rowe Price153 investments · 69 on the map · $16B raised
Andreessen Horowitz548 investments · 482 on the map · $32.6B raised
Menlo Ventures266 investments · 177 on the map · $6.2B raised
Fidelity223 investments · 153 on the map · $17.4B raised
OrbiMed177 investments · 137 on the map · $9.6B raised
BlackRock196 investments · 116 on the map · $13.9B raised